Diabetes

News

Embattled Better gets FDA okay for lead DTx product

Digital health company Better Therapeutics has the FDA approval for lead digital therapeutic (DTx) AspyreRx for type 2 diabetes it was hoping for – but now it has to conve

News

Study shows digital Dario tool effective in severe diabetes

A digital tool being developed by DarioHealth and Sanofi has been shown to improve blood glucose control in a real-world study reported at the American Diabetes Associatio

News

Lilly ends ADA on a high as obesity triple data pops

The first reveal of clinical data with Eli Lilly’s injectable triple receptor agonist for obesity suggests that the company could have a big winner on its hands if the dru

News

NICE not convinced yet by Mounjaro for diabetes

Eli Lilly is riding high on new data for its experimental obesity therapies, but i

News

Novo Nordisk, Lilly highlight oral obesity drugs at ADA

New data from Novo Nordisk’s phase 3 trial of an oral, high-dose formulation of semaglutide reinforces its potential as a weight-loss therapy in obesity, but Eli Lilly is

News

Jardiance is first SGLT2 given FDA OK for use in children

With rates of juvenile type 2 diabetes rocketing in the US, doctors now have access to an alternative oral therapy – the first new oral option for more than 20 years.

Embattled Better gets FDA okay for lead DTx product

Study shows digital Dario tool effective in severe diabetes

Lilly ends ADA on a high as obesity triple data pops

NICE not convinced yet by Mounjaro for diabetes

Novo Nordisk, Lilly highlight oral obesity drugs at ADA

Jardiance is first SGLT2 given FDA OK for use in children

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Diabetes

Editor's Picks